Yajin Chen

机构：Sun Yat-sen University, National Clinical Research Center for Digestive Diseases, Sun Yat-sen Memorial Hospital · ORCID：0000-0002-4126-0357

发表论文 104 篇 · 总被引 2901 次 · h-index 20

代表论文

• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 46)
• Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study (2025 · Clinical Cancer Research · 被引 4)
• Laparoscopic Extended Segmentectomy 8 with Right Hepatic Vein Resection After Conversion Therapy for Advanced Intrahepatic Cholangiocarcinoma (2025 · Annals of Surgical Oncology · 被引 2)
• Bile cell-free DNA shows benefit as a potential sample for somatic mutation detection of resectable cholangiocarcinoma (2025 · iLiver · 被引 1)
• TMEM88 modulates the proliferation and metastasis of HCC via the GSK-3β/β-catenin pathway (2025 · BMC Cancer)
• Supplementary Figure S5 from Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma (2025)